P1231: ZILOVERTAMAB VEDOTIN (MK-2140) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE-001 STUDY OF AN ANTI-ROR1 ANTIBODY-DRUG CONJUGATE - M. Wang; M. Mei; P. M. Barr; J. Barrientos; S. de Vos; R. Furman; K. Patel; P. A. Thompson; M. Choi; A. Kallam; Y. Zhu; S. Chakraborty; et al. (HemaSphere, 2022)